Per-Anders Abrahamsson (Former)
51 – 60 of 125
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2009
-
Mark
COMPARING TESTOSTERONE AND PSA FOR DIFFERENT BASELINE TESTOSTERONE CONCENTRATIONS DURING INITIATION OF DEGARELIX AND LEUPROLIDE TREATMENT
2009) 24th Annual Congress of the European Association of Urology In European Urology Supplements 8(4). p.130-130(
- Contribution to journal › Published meeting abstract
-
Mark
Improving Outcomes in Prostate Cancer: Time to Tackle Bone Disorders
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
European Association of Urology Position Statement on Screening for Prostate Cancer.
(
- Contribution to journal › Letter
-
Mark
The expression of pluripotency marker Oct 3/4 in prostate cancer and benign prostate hyperplasia.
(
- Contribution to journal › Article
-
Mark
The developing role of hormonal therapy in the treatment of prostate cancer.
(
- Contribution to journal › Article
-
Mark
EAU-a work in progress-what comes next?
(
- Contribution to journal › Letter
-
Mark
The effect of a novel botanical agent TBS-101 on invasive prostate cancer in animal models.
(
- Contribution to journal › Article
- 2008
-
Mark
Malignant lesions in the ventral prostate of alloxan-induced diabetic rats
(
- Contribution to journal › Article
-
Mark
PSA-based screening for prostate cancer: How does it compare with other cancer screening tests?
(
- Contribution to journal › Scientific review
-
Mark
Intermittent DHT administration enhances effect of docetaxel in a xenograft model by modulation of ER beta, AR and NEK2
2008) 23rd Annual Congress of the European Association of Urology, 2008 In European Urology Supplements 7(3). p.278-278(
- Contribution to journal › Published meeting abstract